vimarsana.com
Home
Live Updates
Dr Zhang on the Implications of Findings From the KEYNOTE-564 Trial in RCC : vimarsana.com
Dr Zhang on the Implications of Findings From the KEYNOTE-564 Trial in RCC
Tian Zhang, MD, MHS, discusses the implications of subgroup analyses from the KEYNOTE-564 trial in patients with renal cell carcinoma.
Related Keywords
,
Department Of Internal Medicine
,
Haroldc Simmons Comprehensive Cancer Center
,
International Kidney Cancer Symposium
,
Ut Southwestern Medical Center
,
Tian Zhang
,
Internal Medicine
,
Comprehensive Cancer Center
,
Medical Center
,
Kidney Cancer Symposium
,
Cancers Symposium
,
Ut Southwestern Haroldc Simmons Comprehensive Cancer Center
,
Onclive Tv
,
Genitourinary Cancers
,
Nrcc
,
Renal Cell Carcinoma
,
vimarsana.com © 2020. All Rights Reserved.